Skip to main content

Resources | GileadPro

Featured content:

Non-clinical considerations when referring patients for CAR T-cell therapy

Navigating the decision-making process for CAR T-cell therapy can be complex and challenging process for many patients. In this video,
Dr Wendy Osborne and Dr Laura Dunning discuss non-clinical barriers to treatment and highlight how collaborative approaches between referring and treating physicians can support patients in making informed treatment decisions.

Optimising your service

Guidance documents to support healthcare professionals:

Booklets to support your patients:

Websites:

Podcasts and supporting resources:

Stay up to date

Receive email updates from Gilead, including promotional communications.


April 2026 UKI-YES-0524

Adverse events should be reported.

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). For IE, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead to [email protected] or +44(0) 1223 897500 or +353(0) 21 482 5999.